A group of Florida healthcare providers will pay $33 million to settle Gilead's claims the group made fraudulent 340B-related transactions involving the company’s HIV pre-exposure prophylaxis drugs.
Clinics Pay Gilead $33 Million to Settle Fraud Claims Involving 340B-Related PrEP Transactions
One of two groups of Florida health care providers that drug maker Gilead accused of making fraudulent 340B-related transactions involving the company’s HIV pre-exposure prophylaxis drugs agreed last week to settle Gilead’s claims against it for $33 million.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.